대한한방부인과학회지 (The Journal of Korean Obstetrics and Gynecology)

  • 제22권3호
  • /
  • Pages.1-24
  • /
  • 2009
  • /
  • 1229-4292(pISSN)
  • /
  • 2508-3619(eISSN)
대한한방부인과학회 (The Society of Korean Medicine Obstetrics and Gynecology)
권호 표지
DOI QR코드

DOI QR Code

보중익기탕(補中益氣湯)이 실험적으로 유발된 흰쥐의 자궁내막증(子宮內膜症) 발달에 미치는 영향

Effects of Bojungikgi-Tang on the Development of Experimentally-induced Endometriosis in the Rats

  • 이정구 (세명대학교 한의과대학 한방부인과교실) ;
  • 이동녕 (세명대학교 한의과대학 한방부인과교실) ;
  • 서일복 (세명대학교 한의과대학 한방부인과교실) ;
  • 김형준 (세명대학교 한의과대학 한방부인과교실)
  • Lee, Jeong-Gu (Dept. of Oriental Gynecology, College of Oriental Medicine, Se-Myung University) ;
  • Lee, Dong-Nyung (Dept. of Oriental Gynecology, College of Oriental Medicine, Se-Myung University) ;
  • Seo, Il-Bock (Dept. of Oriental Gynecology, College of Oriental Medicine, Se-Myung University) ;
  • Kim, Hyung-Jun (Dept. of Oriental Gynecology, College of Oriental Medicine, Se-Myung University)
  • 발행 : 2009.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: This study was performed to investigate the effects of Bojungikgi-Tang on the development of experimentally-induced endometriosis in rats. Methods: Endometriosis was induced in rats by autotransplanting uterine tissue to the peritoneum and we divided the rats into three groups: (1) sham-operated group (n=8), (2) surgically induced endometriosis and untreated control group(n=8), (3) surgically induced endometriosis and Bojungikgi-Tang treated group. Bojungikgi-Tang was orally administrated for 15 days after operation. Then we measured the body weight, the volume of endometriotic implants, the weight of uterus and ovary, and analysed the concentration of cytokines(MCP-1, TNF-${\alpha}$, IL-1${\beta}$, IL-6) in peritoneal fluids. Histopathology, immunohistochemistry for COX-2 and VEGF, and histochemistry for mast cell in transplanted uterine tissue were also performed. Results: 1. The volume($mm^3$) of endometriotic implants in Bojungikgi-Tang treated group(129${\pm}$39) was significantly decreased(p<0.05) compared with control group(222${\pm}$109). 2. The concentration(pg/$m{\ell}$) of MCP-1 in peritoneal fluids in Bojungikgi-Tang treated group(1012${\pm}$248) was significantly decreased(p<0.05) compared with control group(1413${\pm}$346). 3. The concentration(pg/$m{\ell}$ of TNF-${\alpha}$ in peritoneal fluids in Bojungikgi-Tang treated group(887${\pm}$196) was significantly decreased(p<0.05) compared with control group(1126${\pm}$140). 4. Histopathologically, proliferation of endometriotic epithelia, infiltration of inflammatory cells and angiogenesis in transplanted uterine tissue of Bojungikgi-Tang treated group were weakly observed than those of control group. 5. The percentage of positive epithelial layers for COX-2 in Bojungikgi-Tang treated group(56${\pm}$17) was significantly decreased(p<0.05) compared with control group(75${\pm}$16). 6. The VEGF expression of endometriotic epithelia, neovascular endothelia and stromal cells in transplanted uterine tissue of Bojungikgi-Tang treated group were weakly observed than those of control group. Conclusion: On the basis of these results, we concluded that Bojungikgi-Tang has inhibiting effects on the development of transplanted uterine tissue. And these effects may be related with decreased production of MCP-1, TNF-${\alpha}$, and decreased expression of COX-2 and VEGF infiltration by administration of Bojungikgi-Tang.

키워드

참고문헌

  1. Hammond CB, Hancy AF. Conservative treatment of endometriosis. Fertil Steril. 1978;30:497-509. https://doi.org/10.1016/S0015-0282(16)43628-9
  2. 대한산부인과학회 교과서 편찬위원회. 부인과학(제4판). 서울:도서출판 고려 의학. 2007:399-430.
  3. 한의부인과학 교재편찬 위원회. 한의 부인과학 상권. 서울:도서출판 정담. 2001:96, 137, 171, 172, 182, 186, 279, 280, 287, 291, 326, 380.
  4. Winkel CA. Evaluation and management of women with endometriosis. Obstet Gynecol. 2003;102:397-408. https://doi.org/10.1016/S0029-7844(03)00474-5
  5. Smith S, Pfiefer SM, Collins J. Diagnosis and management of female infertility. JAMA. 2003;290:17.
  6. ASRM Practice Committee Report. A Committee Opinion: endometriosis infertility. Fertil Steril. 2004;81:1441-6. https://doi.org/10.1016/j.fertnstert.2004.01.019
  7. Kennedy SH. Is there a genetic basis to endometriosis?. Semin Reprod Endocrino. 1997;15:309-17. https://doi.org/10.1055/s-2008-1068761
  8. Halme J et al. Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am J Obstet Gynecol. 1983;145(3):333-7. https://doi.org/10.1016/0002-9378(83)90720-2
  9. Koyama N, Matsuura K, Okamura H. Cytokines in the peritoneal fluid of patients with endometriosis. Int J Gynecol Obstet. 1993;43(1):45-50. https://doi.org/10.1016/0020-7292(93)90273-Y
  10. Hughes E, Fedorkow DM, Collins J. A quantitative overview of controlled trials in endometriosis-associated infertility. Fertil Steril. 1993;59:963-70.
  11. Winkel CA, Scialli AR. Medical and surgical therapies for pain associated with endometriosis. J Womens Health Gend Based Med. 2001;10:137-62. https://doi.org/10.1089/152460901300039485
  12. Takayama K et al. Treatment of serve postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril. 1998;69:709-13. https://doi.org/10.1016/S0015-0282(98)00022-3
  13. Ailawadi RK et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone:a pilot study. Fertil Steril. 2004;81:290-6. https://doi.org/10.1016/j.fertnstert.2003.09.029
  14. Canis M et al. Laparoscopic treatment of endometriosis. Acta Obstet Gynecol Scand Suppl. 1989;150:15-20.
  15. Nisolle-Pochet M, Casanas-Roux F, Donnez J. Histologic study of ovarian endometriosis after hormonal therapy. Fertil Steril. 1988;49(3):423-6. https://doi.org/10.1016/S0015-0282(16)59766-0
  16. 보건복지부. 子宮內膜症의 새로운 진단, 치료 및 예방법 개발-1998년도 보건의료 기술 연구. 개발사업 최종고서. 1999;2-108.
  17. 김동일, 이동규, 이태균. 子宮內膜症의 韓醫學 治療에 관한 硏究. 大韓韓方婦人科學會誌. 2002;15(2):126-43.
  18. 최변탁 등. 芎歸調血飮이 흰쥐의 子宮內膜症 형성 억제에 미치는 영향. 大韓韓方婦人科學會誌. 2008;21(3):34-59.
  19. 이태균. 子宮內膜症에 대한 文獻的 考察. 大韓韓方婦人科學會誌. 1995;8(1):161-74.
  20. 오규석, 홍영욱, 이태균. 血府逐瘀湯이 子宮內膜症 白鼠에 미치는 영향. 대한한의학회지. 1995;18(2):273-82.
  21. 김동일, 이태균. 子宮內膜症 및 만성 지속성 간염과 병발한 원발성 불임증 1례에 대한 치험 보고. 대한한의학회지. 1998;19(1):100-8.
  22. 권은정, 배한익, 이태균. 內膜Ⅰ號丸의 子宮內膜症 白鼠의 치료효과에 대한 연구. 東國論集. 1996;15:325-42.
  23. 이동규, 김순열, 이태균. 內膜Ⅱ號丸의 phospolipase A2 활성 억제능에 관한 연구. 大韓韓方婦人科學會誌. 1996;9(1) :97-107.
  24. 김동일, 이태균. 子宮內膜症 환자 2례에 대한 임상적 고찰. 대한한의학회지. 1997;18(2):58-71.
  25. 김여태 등. 加味歸朮破癥湯이 실험적으로 유발된 흰쥐의 子宮內膜症에 미치는 영향. 大韓韓方婦人科學會誌. 2006 ;19(2):162-85.
  26. 김형일, 임은미, 권기록. 溫經湯이 子宮內膜症 유발 白鼠에 미치는 영향. 大韓韓方婦人科學會誌. 2006;19(2):18-33.
  27. 윤영희 등. 少腹逐瘀湯이 실험적으로 유발된 흰쥐의 子宮內膜症에 미치는 영향. 大韓韓方婦人科學會誌. 2006;19(2) :141-61.
  28. 장성환, 임은미, 이은. 桃紅四物湯이 子宮內膜症을 유발한 흰쥐에 미치는 영향. 大韓韓方婦人科學會誌. 2006;19(2) :125-38.
  29. 이지연, 임은미, 권기록. 加味紅藤湯 직장 내 투여가 子宮內膜症을 유발한 흰쥐에 미치는 영향. 大韓韓方婦人科學會誌. 2006;19(3):109-20.
  30. 김철수 등. 膈下逐瘀湯이 실험적으로 유발된 흰쥐의 子宮內膜症에 미치는 영향. 大韓韓方婦人科學會誌. 2007;20(1) :61-83.
  31. 허윤, 임은미, 이은. 丹蔘이 子宮內膜症 白鼠에 미치는 영향. 大韓韓方婦人科學會誌. 2006;19(3):95-107.
  32. 육상숙, 임은미, 권기록. 中性瘀血藥鍼이 子宮內膜症 白鼠에 미치는 영향. 대한약침학회지. 2006;9(1):83-94.
  33. 박준식, 임은미, 이은. 浦公英 추출물이 子宮內膜症 유발 白鼠에 미치는 영향. 大韓韓方婦人科學會誌. 2006;19(3):69-82.
  34. 이현희, 김윤상, 임은미. 黃芩의 경구 와 직장투여가 실험적으로 유발된 子宮內膜症에 미치는 영향. 大韓韓方婦人科學會誌. 2008;21(3):1-17.
  35. 이미정, 임은미, 권기록. 八珍湯이 子宮內膜症을 유발한 흰쥐에 미치는 영향. 大韓韓方婦人科學會誌. 2006;19(3):83-94.
  36. 임성민. 補陽還五湯이 실험적으로 유발된 흰쥐의 子宮內膜症에 미치는 영향. 세명대학교 대학원 한의학과 박사학위논문. 2008.
  37. 주병주. 當歸芍藥散이 실험적으로 유발된 흰쥐의 子宮內膜症에 미치는 영향. 세명대학교 대학원 한의학과 박사학위논문. 2008.
  38. 조현주, 김윤상, 임은미. 黃芪가 子宮內膜症 유발 흰쥐에 미치는 영향. 大韓韓方婦人科學會誌. 2007;20(2):43-59.
  39. 김성혜, 권기록, 박희수. 山蔘藥鍼이 子宮內膜症 유발 흰쥐에 미치는 영향. 대한침구학회지. 2006;23(5):55-67.
  40. 李杲.. 東垣十種醫書. 上海:鴻文局版. 1975:33, 34, 85, 86.
  41. 金相贊 등. 方劑學-改正增補版. 서울: 도서출판 永林社. 1999:279-81.
  42. 尹用甲. 補中益氣湯 및 加減方이 白鼠와 家兎의 摘出子宮, 腸 및 血管運動에 미치는 影響. 方劑學會. 1992;3(1):53-80.
  43. 김동일 등. 補中益氣湯 과립제(보로)의 한방부인과 임상응용 경향 분석과 월경기간 중 활용에 대한 제언. 大韓韓方婦人科學會誌. 2005;18(2):148-58.
  44. 정형민 등 .교애궁귀탕, 보중익기탕,궁소산, 안태음, 안태금출탕을 투약한 임신생쥐의 생식능력의 변화. 대한한의학회지. 2000;21(3):166-73.
  45. 金惠媛, 李京燮, 宋炳基. 加味補中益氣湯이 肥滿생쥐의 卵巢反應과 姙娠에 미치는 影響. 大韓韓方婦人科學會誌. 2000;13(2):35-45.
  46. 白承嬉. 加味補中益氣湯으로 治療한 卵巢囊腫 治驗例. 東西醫學. 1999;24(3) :1-16.
  47. 宋鐘錫, 柳同烈. 加味補中益氣湯과 子宮下垂의 活用에 관한 考察. 大田大學校 韓醫學硏究所 論文集. 2005;14(2) :205-12.
  48. 許浚 著, 東醫文獻硏究室 編譯. 新編 對譯 東醫寶鑑. 서울:법인문화사. 2005 :2113.
  49. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5) :684-94. https://doi.org/10.1016/S0015-0282(16)48988-0
  50. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update. 2000;6:45-55. https://doi.org/10.1093/humupd/6.1.45
  51. Jonathan S et al. Novak's Gynecology. 12ed Williams & Wilkins, Baltimore. 1996;403, 406, 887-915.
  52. Moen MH. Endometriosis in monozygotic twins. Acta Obstet Gynecol Scand. 1994;73:59-62. https://doi.org/10.3109/00016349409013396
  53. Kennedy S et al. Age of onset of pain symptoms in non-twin sisters concordant for endometriosis. Hum Reprod. 1996;11:403-5. https://doi.org/10.1093/HUMREP/11.2.403
  54. 韓媃程. 한국 여성에서 중증子宮內膜症과 MMP-9 유전자 다형성에 관한 연구. 이화여자대학교 대학원 의학과 석사학위논문. 2007;1.
  55. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol. 1981;141(4):377-83. https://doi.org/10.1016/0002-9378(81)90598-6
  56. Donnez J, Langendonckt AV. Typical and subtle atypical presentations of endometriosis. Med Sci Monit. 2000 ;6(5):1042-6.
  57. 金達鎬, 李鍾馨, 共編譯. 注解補注 黃帝內經 素問. 서울:醫聖堂. 2001:上권:628, 726, 下권:746.
  58. 李慶雨 飜譯. 編注譯解 黃帝內經 靈樞. 서울:여강출판사. 2001:2권:221, 3권:223.
  59. 蔡浩然, 鄭鎭鴻, 金東熙. 加味八珍湯이 免疫調節作用에 미치는 影響. 大韓韓方婦人科學會誌. 1999;12(2):198-224.
  60. 장일무 外 편집부. 동양의과학대전(2) 서울:서울대학교 천연물과학연구소 문헌정보학연구실. 2003:180, 642, 706, 806, 837, 937, 1006.
  61. 江克明, 包明薰. 校正方劑大辭典. 서울:醫聖堂. 1991:567-8.
  62. 김영아 등. 子宮內膜症 자궁내막의 증가된 증식 활성도. 대한산부학회지. 2004;47(7):1334-41.
  63. Abul KA, Andrew HL. 세포분자면역학 제 5판. 서울:도서출판 범문사. 2005:243-74.
  64. Akoun A, et al. Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture. Am J Obstet Gynecol. 1995;172:594-600. https://doi.org/10.1016/0002-9378(95)90578-2
  65. Gazvani R, Templeton A. The peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction. 2002;123:217-26. https://doi.org/10.1530/rep.0.1230217
  66. Barcz E, Kaminsk P, Marianowski L. Role of cytokines in pathogenesis of endometriosis. Medical science monitor. 2000;6(5):1042-6.
  67. Christine J, et al. Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis. American journal of pathology. 1998;152(1):125-33.
  68. Shakida K, Falcone T. Tumor necrosis factor-$\alpha$ blockers:potentia limitations in the management of advanced endometriosis. Human Reproduction. 2006;21(9):2417-20. https://doi.org/10.1093/humrep/del179
  69. Overton C, et al. Peritoneal fluid cytokines and the relationship with endometriosis and pain. Hum Reprod. 1996;11(2):380-6. https://doi.org/10.1093/HUMREP/11.2.380
  70. Hill JA, et al. Effects of soluble products of activated lymphocytes and macrophages (lymphokines and monokines) on human sperm motion parameters. Fertil Steril. 1987;47(3):460-5. https://doi.org/10.1016/S0015-0282(16)59056-6
  71. Lebovic DI, et al. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by Interleukin-1beta. Mol Hum Reprod. 2000;6(3) :269-75. https://doi.org/10.1093/molehr/6.3.269
  72. Arici A, et al. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod. 1996;2(1):40-45. https://doi.org/10.1093/molehr/2.1.40
  73. Vigano P, et al. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod. 1998;4(12):1150-6. https://doi.org/10.1093/molehr/4.12.1150
  74. Akoun A, et al. Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Human Reproduction. 1996;11(10):2269-75. https://doi.org/10.1093/oxfordjournals.humrep.a019088
  75. Gorospe WC, Hughes FM Jr, Spangelo BL. Interleukin-6:effects on and production by rat granulosa cells in vitro. Endocrinology. 1992;130(3):1750-2. https://doi.org/10.1210/en.130.3.1750
  76. Cheong YC, et al. IL-1, IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions. Hum Reprod. 2002 17(1):69-75. https://doi.org/10.1093/humrep/17.1.69
  77. Fletcher BS, et al. Structure of the itogen-inducible TIS10 gene and emonstration that the TIS10-encoded protein is a functional prostagland in G/H synthase. J Biol Chem. 1992;23(2):207-14.
  78. Harada T, et al. Role of cytokines in progression of endometriosis. Gynecol Obstet Invest. 1999;47(1):34-40. https://doi.org/10.1159/000052857
  79. Donnez J, et al. Vascular endothelial growth factor(VEGF) in endometriosis. Hum Reprod. 1998;13(6):1686-90. https://doi.org/10.1093/humrep/13.6.1686
  80. Tsujii M, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:706-16.
  81. Matsuzaki S, et al. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril. 2004;82(6):1609-15. https://doi.org/10.1016/j.fertnstert.2004.07.946
  82. Tischer E, et al. Vascular endothelial growth factor:a new member of the platelet derived growth factor gene family. Biochem Biophys Res Commun. 1989;165:1198-206. https://doi.org/10.1016/0006-291X(89)92729-0
  83. McLaren J, et al. Vascular endothelial growth factor(VEGF) concentrations are elevated in peritoneal flud of women with endometriosis. Hum Reprod 1996;11:220-3. https://doi.org/10.1093/oxfordjournals.humrep.a019023
  84. 이재춘 등. 이식신 생검에서 비만세포의 임상적 의의. 대한외과학회지. 2002;63(3):201-5.
  85. Sugamata M, Ihara T, Uchiide I. Increase of activated mast cells in human endometriosis. American journal of reproductive immunology. 2005;53(3):120-5. https://doi.org/10.1111/j.1600-0897.2005.00254.x
  86. Nguyen M, Pace AJ, Koller BH. Age-induced reprogramming of mast cell deglanuation. The journal of immunology. 2005;175:5701-7.
  87. Xiang Xu, et al. Roles of mast cells and myofibloblasts in human peritoneal adhesion formation. Annals of surgery. 2002;236(5):593-601. https://doi.org/10.1097/00000658-200211000-00009